跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 55 条关于
“Medaxis”
全部
55
临床试验
30
药物
3
机构
8
资讯
14
去年
Clinical Trial Data Quality Hinges on Site-Level Management, Experts Emphasize at OCT Medical Devices 2025
去年
Ultimovacs' Phase II FOCUS Trial of UV1 in Head and Neck Cancer Fails to Meet Endpoints
去年
FDA Clears Groundbreaking AI Surgical Guidance Platforms from Proprio and Medivis
8个月前
Modalis Publishes Breakthrough CRISPR Gene Activation Study for Rare Muscular Dystrophy Treatment
去年
Ultimovacs' UV1 Fails to Improve Outcomes in Head and Neck Cancer Trial
去年
Ultimovacs' UV1 Fails to Meet Endpoints in Phase II HNSCC Trial
去年
FDA Grants Rare Pediatric Disease Designation to Modalis Therapeutics' MDL-101 for Genetic Disorder Treatment
去年
MDL-101 Receives FDA Rare Pediatric Disease Designation for LAMA2-CMD Treatment
2年前
FDA Extends Review of Treosulfan NDA for AML and MDS Treatment
去年
Modalis Therapeutics Receives FDA Orphan Drug Designation for MDL-101 in LAMA2-CMD Treatment
第 1 页,共 2 页
上一页
下一页